Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Abbott Laboratories Q3 Earnings Preview
Abbott Laboratories (ABT) Q3 2024 Earnings Call Highlights: Strong Growth in Diabetes Care and ...
Abbott Laboratories (ABT) reports robust sales growth in key segments despite challenges in nutrition and diagnostics.
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
Welcome to Abbott's third quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by Abbott. With the exception of any participants questions asked during the question-and-answer session,
Abbott Labs beats Q3 sales and earnings expectations, raises full-year outlook
Abbott Laboratories on Wednesday reported better-than-expected third-quarter earnings and sales, boosted by strength in the company’s medical-devices business.
Benzinga.com
1d
Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast
Abbott
's
Q3
sales reached $10.64B, beating the consensus of $10.55B ... beating the analyst estimates of $1.20. Also Read ...
1d
on MSN
Abbott Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Abbott Laboratories (NYSE:ABT) will release earnings results for its third quarter, before the opening bell on Wednesday, Oct ...
19h
High-Quality Abbott Stock: Corporate Growth That Pays You to Own It
Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results ...
7h
Abbott Laboratories: Balanced Prospects Lead to Hold Recommendation Amid Market Adjustments
Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) today and set a price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback